针对具有鼻息肉的慢性鼻炎中的IL-4/IL-13信号通路:从机制到疗法
Jiani Chen1,2, Chen Zhang1,2, Qianqian Zhang1,2
1High Altitude Rhinology Research Center, Eye & ENT Hospital of Fudan University, 83 Fenyang Road, Shanghai, 200031, China.
Clinical reviews in allergy & immunology
|September 18, 2025
概括
具有鼻息肉的慢性鼻鼻炎 (CRSwNP) 涉及持续的鼻鼻炎炎症. 准介质素-4/介质素-13 (IL-4/IL-13) 途径显示出治疗这种疾病的希望.
科学领域:
- 免疫学 免疫学 免疫学
- 耳鼻喉科 耳鼻喉科 耳鼻喉科
- 药理学 药理学是指药理学的学科.
背景情况:
- 带鼻息肉的慢性鼻炎 (CRSwNP) 是一种影响上呼吸道的普遍炎症状况.
- 鼻腔粘膜的持续炎症和鼻的多胞体发展是CRSwNP的特征.
- 介素-4/介素-13 (IL-4/IL-13) 信号通路在CRSwNP的发病过程中起着至关重要的作用.
研究的目的:
- 提供CRSwNP中IL-4/IL-13通路的简要概述.
- 详细介绍CRSwNP中IL-4/IL-13信号传递的分子结构和致病机制.
- 审查针对CRSwNP的IL-4/IL-13通路的当前和新兴治疗策略.
主要方法:
- 对CRSwNP中的IL-4/IL-13信号研究的文献综述.
- 基于IL-4/IL-13参与的分子机制的分析.
- 对目标生物制剂的临床数据的评估.
主要成果:
- IL-4/IL-13通路是CRSwNP的核心.
- 针对IL-4/IL-13的生物药物已经证明了显著的临床疗效.
- 目前正在开发各种治疗策略来调节这种途径.
结论:
- IL-4/IL-13通路是CRSwNP的一个关键驱动因素.
- 向疗法为CRSwNP患者提供了有效的治疗选择.
- 对新兴策略的进一步研究有可能改善CRSwNP管理.
相关概念视频
Drugs Used in Lower Respiratory Disorders: Overview
1.1K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.1K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
Antiasthma Drugs: Leukotriene Modifiers
1.8K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
1.8K
T Cell Types and Functions
2.2K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.2K
Drugs Used in Upper Respiratory Disorders: Overview
631
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
631
Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K


